U.S. Vaccine Policy Shifts Under RFK Jr. Create Uncertainty for Pharma and Investors 
TrumpRx.gov Highlights GLP-1 Drug Discounts but Offers Limited Savings for Most Americans 
Gold and Silver Prices Slide as Dollar Strength and Easing Tensions Weigh on Metals 
Instagram Outage Disrupts Thousands of U.S. Users 
Trump Signs Executive Order Threatening 25% Tariffs on Countries Trading With Iran 
Trump Endorses Japan’s Sanae Takaichi Ahead of Crucial Election Amid Market and China Tensions 
Russian Stocks End Mixed as MOEX Index Closes Flat Amid Commodity Strength 
Bank of Japan Signals Readiness for Near-Term Rate Hike as Inflation Nears Target 
Vanda Pharmaceuticals Wins FDA Approval for New Motion Sickness Drug After Four Decades 
Once Upon a Farm Raises Nearly $198 Million in IPO, Valued at Over $724 Million 
South Korea’s Weak Won Struggles as Retail Investors Pour Money Into U.S. Stocks 
Alphabet’s Massive AI Spending Surge Signals Confidence in Google’s Growth Engine 
Blue Origin’s New Glenn Achieves Breakthrough Success With First NASA Mission 
Amazon Stock Rebounds After Earnings as $200B Capex Plan Sparks AI Spending Debate 
RBI Holds Repo Rate at 5.25% as India’s Growth Outlook Strengthens After U.S. Trade Deal 
SpaceX Starship Explodes in Texas During Test, Citing Nitrogen Tank Failure 
A South Korean research team has developed a strip-type urine test that successfully diagnoses prostate and pancreatic cancer on-site by amplifying the optical signal of the metabolome in urine.
The joint research team is from the Korea Institute of Materials Science, Pohang University of Science and Technology, and Kyung Hee University
The surface-enhanced Raman scattering sensor that they developed can amplify the optical signal of the metabolome in urine by more than 1 billion times by forming a coral reef-shaped plasmonic nanomaterial on top of porous paper material.
A light irradiation after a 10-microliter urine droplet amplified signal of cancer metabolome on the sensor’s surface without the need to go through a separate analysis process,.
The application of an artificial intelligence-based analytical method for the spectrum signal generated through the irradiation of light into the urine can identify people with prostate cancer and pancreatic cancer with an accuracy of up to 99 percent.
